EZH2/EHMT2 Histone Methyltransferases Inhibit the Transcription of DLX5 and Promote the Transformation of Myelodysplastic Syndrome to Acute Myeloid Leukemia

MLA

Zhuanzhen Zheng, et al. “EZH2/EHMT2 Histone Methyltransferases Inhibit the Transcription of DLX5 and Promote the Transformation of Myelodysplastic Syndrome to Acute Myeloid Leukemia.” Frontiers in Cell and Developmental Biology, vol. 9, Aug. 2021. EBSCOhost, https://doi.org/10.3389/fcell.2021.619795.

APA

Zhuanzhen Zheng, Ling Li, Guoxia Li, Yaofang Zhang, Chunxia Dong, Fanggang Ren, Wenliang Chen, & Yanping Ma. (2021). EZH2/EHMT2 Histone Methyltransferases Inhibit the Transcription of DLX5 and Promote the Transformation of Myelodysplastic Syndrome to Acute Myeloid Leukemia. Frontiers in Cell and Developmental Biology, 9. https://doi.org/10.3389/fcell.2021.619795

Chicago

Zhuanzhen Zheng, Ling Li, Guoxia Li, Yaofang Zhang, Chunxia Dong, Fanggang Ren, Wenliang Chen, and Yanping Ma. 2021. “EZH2/EHMT2 Histone Methyltransferases Inhibit the Transcription of DLX5 and Promote the Transformation of Myelodysplastic Syndrome to Acute Myeloid Leukemia.” Frontiers in Cell and Developmental Biology 9 (August). doi:10.3389/fcell.2021.619795.